Brandon Folkes Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Brandon Folkes

    Stock Analyst at HC Wainwright & Co.

    (3.8)
    # 2200
    Out of 5,506 analysts
    104
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare
    Top Industries:
    Biotechnology Drug Manufacturers - Specialty & Generic Medical - Instruments & Supplies

    44 Stocks

    Name Action PT Current % Upside Ratings Updated
    GNFT Genfit
    Maintains: Buy
    9 7
    		4 75% 2 Sep 24, 2025
    RNTX Rein Therapeutics
    Initiates Coverage On: Buy
    10
    		1.19 740.34% 1 Sep 22, 2025
    MNKD MannKind
    Reiterates: Buy
    11 11
    		5.76 90.97% 5 Sep 18, 2025
    ANIP ANI Pharmaceuticals
    Maintains: Strong Buy
    93 121
    		89.64 34.98% 6 Sep 17, 2025
    VALN Valneva
    Reiterates: Buy
    18 18
    		11.39 58.03% 2 Aug 25, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    13
    		7.33 77.35% 2 Aug 25, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    12
    		3.15 280.95% 2 Aug 21, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    12 12
    		5.85 105.13% 3 Aug 20, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    13 13
    		3.51 270.37% 4 Aug 13, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    7 7
    		1.49 369.8% 2 Aug 13, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Buy
    10
    		8.2 21.95% 1 Aug 12, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Buy
    44
    		34.61 27.13% 6 Aug 11, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    20 17
    		11.34 49.91% 3 Aug 8, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Buy
    29
    		7.29 297.81% 1 Aug 7, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    28
    		23.17 20.85% 1 Aug 6, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Buy
    20
    		10.33 93.61% 1 Jul 28, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    26
    		9.75 166.67% 1 Jul 2, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    6
    		1.32 354.55% 2 Jun 9, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Buy
    5
    		2.11 136.97% 2 Jun 5, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    9
    		1.07 741.12% 1 Jun 2, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    21
    		9.88 112.55% 2 May 28, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    5
    		1.22 309.84% 1 Nov 14, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    9
    		4.58 96.51% 2 Nov 14, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    8
    		n/a n/a 1 Nov 14, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    16 16
    		9.14 75.05% 6 Sep 13, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    10
    		0.51 1860.78% 2 Jun 13, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    455
    		15.72 2794.4% 1 Jun 13, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    59
    		31.19 89.16% 4 Sep 26, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    8
    		n/a n/a 4 Sep 7, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    180
    		139.48 29.05% 2 Aug 22, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    25 15
    		n/a n/a 2 Jan 10, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    300 220
    		3.8 5689.47% 3 Dec 5, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    5
    		n/a n/a 1 Nov 2, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    6
    		n/a n/a 1 Jun 3, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Overweight
    28 32
    		31.06 3.03% 3 Jan 27, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    40
    		n/a n/a 1 Sep 22, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    22000
    		1.9 1157794.74% 1 Aug 31, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    3125
    		n/a n/a 1 Aug 28, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    38 53
    		n/a n/a 4 Aug 20, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    405 315
    		n/a n/a 3 Mar 5, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    58 46
    		n/a n/a 6 Mar 2, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    32 42
    		n/a n/a 2 Sep 28, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    42 50
    		15.81 216.26% 1 Jul 12, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    7 4
    		n/a n/a 2 Mar 13, 2018